Targeting chitinase-3-like protein 2 (CHI3L2) suppresses cell proliferation and migration in glioblastoma

Read full text Summarise with VIRAT
Authors: Zhihong Liu, Dihui Chen, Sijia Liao, Xiuyue Fan, Jiamei Wang, Haiying Yue, Huilin Shen, Jijin Wang, Chengning Zhao, Rong Hu, Guangshi Du, Feng Han
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Glioblastoma (GBM), the most common and aggressive subtype of glioma, currently lacks effective therapeutic targets. This study aimed to elucidate the role of chitinase-3-like protein 2 (CHI3L2) and its underlying mechanism in GBM cell proliferation and migration. Methods: Gene Expression Profiling Interactive Analysis 2 (GEPIA2) and Chinese Glioma Genome Atlas (CGGA) databases were used to analyze the messenger RNA (mRNA) expression level of CHI3L2 and its prognostic significance in different grades of glioma patients. Western blotting was performed to determine the protein levels of CHI3L2 in different GBM cell lines. The efficiency of lentivirus-mediated CHI3L2 knockdown or overexpression was tested by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting in LN-229 and U251 cells. Cell proliferation was determined by cell counting kit-8 (CCK-8) and 5-ethynyl-2'-deoxyuridine (EdU) assays. Cell migration was detected by the wound healing assay. Cell cycle distribution was analyzed by flow cytometry. Protein levels of key cell cycle-related regulators (e.g., c-MYC, CDK2, CDK4) and migration-related regulators (e.g., E-cadherin, N-cadherin, MMP2, MMP9) were measured by Western blotting. Results: Integrated bioinformatics analysis demonstrated that high CHI3L2 expression was correlated with shortened overall survival (OS) and disease-free survival (DFS) in GBM patients. CHI3L2 knockdown significantly suppressed cell proliferation, G1/S transition, and cell migration in LN-229 and U251 cells; conversely, CHI3L2 overexpression facilitated these cellular processes. Furthermore, CHI3L2 knockdown markedly reduced the protein levels of c-MYC, CDK2, CDK4, N-cadherin, MMP2, and MMP9 but increased E-cadherin. Conclusions: Elevated CHI3L2 expression drives GBM cell proliferation and migration, suggesting that CHI3L2 is a promising therapeutic target for GBM.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Studies on Chitinases and Chitosanases Cholangiocarcinoma and Gallbladder Cancer Studies

Publication details

Journal / source
Translational Cancer Research
Volume
15
Issue
3
Pages
146–146
Publication date
1 March 2026
Language
EN